BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Román E, Torrades MT, Nadal MJ, Cárdenas G, Nieto JC, Vidal S, Bascuñana H, Juárez C, Guarner C, Córdoba J, Soriano G. Randomized Pilot Study: Effects of an Exercise Programme and Leucine Supplementation in Patients with Cirrhosis. Dig Dis Sci 2014;59:1966-75. [DOI: 10.1007/s10620-014-3086-6] [Cited by in Crossref: 105] [Cited by in F6Publishing: 103] [Article Influence: 13.1] [Reference Citation Analysis]
Number Citing Articles
1 Kitajima Y, Takahashi H, Akiyama T, Murayama K, Iwane S, Kuwashiro T, Tanaka K, Kawazoe S, Ono N, Eguchi T, Anzai K, Eguchi Y. Supplementation with branched-chain amino acids ameliorates hypoalbuminemia, prevents sarcopenia, and reduces fat accumulation in the skeletal muscles of patients with liver cirrhosis. J Gastroenterol. 2018;53:427-437. [PMID: 28741271 DOI: 10.1007/s00535-017-1370-x] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 10.8] [Reference Citation Analysis]
2 Ney M, Tangri N, Dobbs B, Bajaj J, Rolfson D, Ma M, Ferguson T, Bhardwaj P, Bailey RJ, Abraldes J, Tandon P. Predicting Hepatic Encephalopathy-Related Hospitalizations Using a Composite Assessment of Cognitive Impairment and Frailty in 355 Patients With Cirrhosis. Am J Gastroenterol 2018;113:1506-15. [PMID: 30267028 DOI: 10.1038/s41395-018-0243-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
3 Plauth M, Bernal W, Dasarathy S, Merli M, Plank LD, Schütz T, Bischoff SC. ESPEN guideline on clinical nutrition in liver disease. Clin Nutr 2019;38:485-521. [PMID: 30712783 DOI: 10.1016/j.clnu.2018.12.022] [Cited by in F6Publishing: 113] [Reference Citation Analysis]
4 Kappus MR, Mendoza MS, Nguyen D, Medici V, Mcclave SA. Sarcopenia in Patients with Chronic Liver Disease: Can It Be Altered by Diet and Exercise? Curr Gastroenterol Rep 2016;18. [DOI: 10.1007/s11894-016-0516-y] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
5 Al-judaibi B, Alqalami I, Sey M, Qumosani K, Howes N, Sinclair L, Chandok N, Eddin AH, Hernandez-alejandro R, Marotta P, Teriaky A. Exercise Training for Liver Transplant Candidates. Transplantation Proceedings 2019;51:3330-7. [DOI: 10.1016/j.transproceed.2019.08.045] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
6 Yang YJ, Kim DJ. An Overview of the Molecular Mechanisms Contributing to Musculoskeletal Disorders in Chronic Liver Disease: Osteoporosis, Sarcopenia, and Osteoporotic Sarcopenia. Int J Mol Sci 2021;22:2604. [PMID: 33807573 DOI: 10.3390/ijms22052604] [Reference Citation Analysis]
7 Thandassery RB, Montano-Loza AJ. Role of Nutrition and Muscle in Cirrhosis. Curr Treat Options Gastroenterol. 2016;14:257-273. [PMID: 27023701 DOI: 10.1007/s11938-016-0093-z] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 5.3] [Reference Citation Analysis]
8 Morkane CM, Kearney O, Bruce DA, Melikian CN, Martin DS. An Outpatient Hospital-based Exercise Training Program for Patients With Cirrhotic Liver Disease Awaiting Transplantation: A Feasibility Trial. Transplantation 2020;104:97-103. [DOI: 10.1097/tp.0000000000002803] [Cited by in Crossref: 15] [Cited by in F6Publishing: 1] [Article Influence: 7.5] [Reference Citation Analysis]
9 Essam Behiry M, Mogawer S, Yamany A, Rakha M, Awad R, Emad N, Abdelfatah Y. Ability of the Short Physical Performance Battery Frailty Index to Predict Mortality and Hospital Readmission in Patients with Liver Cirrhosis. Int J Hepatol 2019;2019:8092865. [PMID: 31186966 DOI: 10.1155/2019/8092865] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
10 Yoshiji H, Nagoshi S, Akahane T, Asaoka Y, Ueno Y, Ogawa K, Kawaguchi T, Kurosaki M, Sakaida I, Shimizu M, Taniai M, Terai S, Nishikawa H, Hiasa Y, Hidaka H, Miwa H, Chayama K, Enomoto N, Shimosegawa T, Takehara T, Koike K. Evidence-based clinical practice guidelines for liver cirrhosis 2020. Hepatol Res 2021;51:725-49. [PMID: 34228859 DOI: 10.1111/hepr.13678] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
11 Li AA, Kim D, Ahmed A. Association of Sarcopenia and NAFLD: An Overview. Clin Liver Dis (Hoboken). 2020;16:73-76. [PMID: 32922754 DOI: 10.1002/cld.900] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
12 Rabiee A, Ximenes RO, Nikayin S, Hickner A, Juthani P, Rosen RH, Garcia-Tsao G. Factors associated with health-related quality of life in patients with cirrhosis: a systematic review. Liver Int 2021;41:6-15. [PMID: 32998172 DOI: 10.1111/liv.14680] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
13 Gluud LL, Dam G, Les I, Córdoba J, Marchesini G, Borre M, Aagaard NK, Vilstrup H. Branched-chain amino acids for people with hepatic encephalopathy. Cochrane Database Syst Rev 2015;:CD001939. [PMID: 26377410 DOI: 10.1002/14651858.CD001939.pub3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
14 Barbero-Becerra VJ, López-Méndez I, Romo-Araiza A, Visag-Castillo V, Chávez-Tapia NC, Uribe M, Juárez-Hernandez E. Sarcopenia in chronic liver diseases: a translational overview. Expert Rev Gastroenterol Hepatol 2020;14:355-66. [PMID: 32299261 DOI: 10.1080/17474124.2020.1757427] [Reference Citation Analysis]
15 Williams FR, Berzigotti A, Lord JM, Lai JC, Armstrong MJ. Review article: impact of exercise on physical frailty in patients with chronic liver disease. Aliment Pharmacol Ther 2019;50:988-1000. [PMID: 31502264 DOI: 10.1111/apt.15491] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 11.0] [Reference Citation Analysis]
16 Silva LD, Bering T, Rocha GA. The impact of nutrition on quality of life of patients with hepatitis C. Curr Opin Clin Nutr Metab Care 2017;20:420-5. [PMID: 28617708 DOI: 10.1097/MCO.0000000000000396] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
17 Nardelli S, Gioia S, Ridola L, Carlin M, Cioffi AD, Merli M, Riggio O, Spagnoli A. Risk of falls in patients with cirrhosis evaluated by timed up and go test: Does muscle or brain matter more? Dig Liver Dis 2021:S1590-8658(21)00333-9. [PMID: 34233863 DOI: 10.1016/j.dld.2021.06.019] [Reference Citation Analysis]
18 Carey EJ, Lai JC, Sonnenday C, Tapper EB, Tandon P, Duarte-Rojo A, Dunn MA, Tsien C, Kallwitz ER, Ng V, Dasarathy S, Kappus M, Bashir MR, Montano-Loza AJ. A North American Expert Opinion Statement on Sarcopenia in Liver Transplantation. Hepatology 2019;70:1816-29. [PMID: 31220351 DOI: 10.1002/hep.30828] [Cited by in Crossref: 75] [Cited by in F6Publishing: 65] [Article Influence: 25.0] [Reference Citation Analysis]
19 Merli M, Iebba V, Giusto M. What is new about diet in hepatic encephalopathy. Metab Brain Dis. 2016;31:1289-1294. [PMID: 26419384 DOI: 10.1007/s11011-015-9734-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
20 Lucero C, Verna EC. The Role of Sarcopenia and Frailty in Hepatic Encephalopathy Management. Clin Liver Dis 2015;19:507-28. [PMID: 26195205 DOI: 10.1016/j.cld.2015.04.003] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
21 Saeki C, Takano K, Oikawa T, Aoki Y, Kanai T, Takakura K, Nakano M, Torisu Y, Sasaki N, Abo M, Matsuura T, Tsubota A, Saruta M. Comparative assessment of sarcopenia using the JSH, AWGS, and EWGSOP2 criteria and the relationship between sarcopenia, osteoporosis, and osteosarcopenia in patients with liver cirrhosis. BMC Musculoskelet Disord. 2019;20:615. [PMID: 31878909 DOI: 10.1186/s12891-019-2983-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 6.7] [Reference Citation Analysis]
22 Bischoff SC, Bernal W, Dasarathy S, Merli M, Plank LD, Schütz T, Plauth M. ESPEN practical guideline: Clinical nutrition in liver disease. Clin Nutr 2020;39:3533-62. [PMID: 33213977 DOI: 10.1016/j.clnu.2020.09.001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
23 Mazurak VC, Tandon P, Montano-loza AJ. Nutrition and the transplant candidate: Mazurak et al. Liver Transpl 2017;23:1451-64. [DOI: 10.1002/lt.24848] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
24 Kok B, McNeely M, Watt M, Tandon P. Exercise Only Works If You Do It! The Holy Grail of Adherence. Am J Gastroenterol 2021;116:673-4. [PMID: 33982935 DOI: 10.14309/ajg.0000000000001198] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Macías-Rodríguez RU, Ilarraza-Lomelí H, Ruiz-Margáin A, Ponce-de-León-Rosales S, Vargas-Vorácková F, García-Flores O, Torre A, Duarte-Rojo A. Changes in Hepatic Venous Pressure Gradient Induced by Physical Exercise in Cirrhosis: Results of a Pilot Randomized Open Clinical Trial. Clin Transl Gastroenterol 2016;7:e180. [PMID: 27415618 DOI: 10.1038/ctg.2016.38] [Cited by in F6Publishing: 57] [Reference Citation Analysis]
26 Brustia R, Scatton O. Pretransplant sarcopenia: suffer or fight? Hepatobiliary Surg Nutr 2017;6:260-3. [PMID: 28848749 DOI: 10.21037/hbsn.2017.03.15] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
27 Nam NH, Kaido T, Uemoto S. Assessment and significance of sarcopenia in liver transplantation. Clin Transplant 2019;33. [PMID: 31651060 DOI: 10.1111/ctr.13741] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
28 Gluud LL, Dam G, Les I, Marchesini G, Borre M, Aagaard NK, Vilstrup H. Branched-chain amino acids for people with hepatic encephalopathy. Cochrane Database Syst Rev. 2017;5:CD001939. [PMID: 28518283 DOI: 10.1002/14651858.cd001939.pub4] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 5.8] [Reference Citation Analysis]
29 Dunn MA. The cost of sarcopenia. Transpl Int 2018;31:155-6. [DOI: 10.1111/tri.13069] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
30 Bezinover D, Geyer NR, Dahmus J, Chinchilli VM, Stine JG. A decline in functional status while awaiting liver transplantation is predictive of increased post-transplantation mortality. HPB (Oxford) 2021:S1365-182X(21)01664-6. [PMID: 34772623 DOI: 10.1016/j.hpb.2021.10.008] [Reference Citation Analysis]
31 de Mello CL, da Conceição TMA, Dal Pont T, Peruzzolo CC, Lúcio MN, Paulin E. The Benefits of Neuromuscular Electrical Stimulation in the Muscular and Functional Capacity of Patients With Liver Cirrhosis: Protocol for a Randomized Clinical Trial. Clin Med Insights Gastroenterol 2018;11:1179552218811834. [PMID: 30505152 DOI: 10.1177/1179552218811834] [Reference Citation Analysis]
32 Brustia R, Savier E, Scatton O. Physical exercise in cirrhotic patients: Towards prehabilitation on waiting list for liver transplantation. A systematic review and meta-analysis. Clin Res Hepatol Gastroenterol 2018;42:205-15. [PMID: 29162460 DOI: 10.1016/j.clinre.2017.09.005] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
33 Bhanji RA, Narayanan P, Allen AM, Malhi H, Watt KD. Sarcopenia in hiding: The risk and consequence of underestimating muscle dysfunction in nonalcoholic steatohepatitis. Hepatology. 2017;66:2055-2065. [PMID: 28777879 DOI: 10.1002/hep.29420] [Cited by in Crossref: 98] [Cited by in F6Publishing: 89] [Article Influence: 19.6] [Reference Citation Analysis]
34 Hey P, Gow P, Testro AG, Apostolov R, Chapman B, Sinclair M. Nutraceuticals for the treatment of sarcopenia in chronic liver disease. Clin Nutr ESPEN 2021;41:13-22. [PMID: 33487256 DOI: 10.1016/j.clnesp.2020.11.015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 8.0] [Reference Citation Analysis]
35 Aamann L, Dam G, Borre M, Drljevic-Nielsen A, Overgaard K, Andersen H, Vilstrup H, Aagaard NK. Resistance Training Increases Muscle Strength and Muscle Size in Patients With Liver Cirrhosis. Clin Gastroenterol Hepatol 2020;18:1179-1187.e6. [PMID: 31394282 DOI: 10.1016/j.cgh.2019.07.058] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
36 West J, Gow PJ, Testro A, Chapman B, Sinclair M. Exercise physiology in cirrhosis and the potential benefits of exercise interventions: A review. J Gastroenterol Hepatol 2021. [PMID: 33638197 DOI: 10.1111/jgh.15474] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
37 Puchades Renau L, Herreras López J, Cebrià I Iranzo MÀ, Cezón Serrano N, Di Maira T, Berenguer M. Frailty and Sarcopenia in Acute-on-Chronic Liver Failure. Hepatol Commun 2021;5:1333-47. [PMID: 34430779 DOI: 10.1002/hep4.1722] [Reference Citation Analysis]
38 Koretz RL. JPEN Journal Club 53. The Narrative Review. JPEN J Parenter Enteral Nutr 2020;44:1355-7. [PMID: 32227597 DOI: 10.1002/jpen.1832] [Reference Citation Analysis]
39 Dos Santos ALS, Anastácio LR. The impact of L-branched-chain amino acids and L-leucine on malnutrition, sarcopenia, and other outcomes in patients with chronic liver disease. Expert Rev Gastroenterol Hepatol 2021;15:181-94. [PMID: 32993404 DOI: 10.1080/17474124.2021.1829470] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
40 Salim T, Stark SA, Duarte-rojo A. Food as Therapy for Frailty. Curr Hepatology Rep 2020;19:23-9. [DOI: 10.1007/s11901-020-00509-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
41 Román E, Parramón M, Flavià M, Gely C, Poca M, Gallego A, Santesmases R, Hernández E, Nieto JC, Urgell E, Alvarado‐tapias E, Vidal S, Ferrero‐gregori A, Vargas V, Guarner C, Soriano G. Frailty in outpatients with cirrhosis: A prospective observational study. Liver Int 2021;41:357-68. [DOI: 10.1111/liv.14694] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
42 Kruger C, McNeely ML, Bailey RJ, Yavari M, Abraldes JG, Carbonneau M, Newnham K, DenHeyer V, Ma M, Thompson R, Paterson I, Haykowsky MJ, Tandon P. Home Exercise Training Improves Exercise Capacity in Cirrhosis Patients: Role of Exercise Adherence. Sci Rep. 2018;8:99. [PMID: 29311671 DOI: 10.1038/s41598-017-18320-y] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 11.8] [Reference Citation Analysis]
43 Bajaj JS, Lauridsen M, Tapper EB, Duarte-rojo A, Rahimi RS, Tandon P, Shawcross DL, Thabut D, Dhiman RK, Romero-gomez M, Sharma BC, Montagnese S. Important Unresolved Questions in the Management of Hepatic Encephalopathy: An ISHEN Consensus. Am J Gastroenterol 2020;115:989-1002. [DOI: 10.14309/ajg.0000000000000603] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
44 Gluud LL, Dam G, Les I, Córdoba J, Marchesini G, Borre M, Aagaard NK, Vilstrup H. Branched-chain amino acids for people with hepatic encephalopathy. Cochrane Database Syst Rev. 2015;2:CD001939. [PMID: 25715177 DOI: 10.1002/14651858.cd001939.pub2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
45 Takada H, Kurosaki M, Nakanishi H, Takahashi Y, Itakura J, Tsuchiya K, Yasui Y, Tamaki N, Takaura K, Komiyama Y, Higuchi M, Kubota Y, Wang W, Okada M, Enomoto N, Izumi N. Impact of pre-sarcopenia in sorafenib treatment for advanced hepatocellular carcinoma. PLoS One 2018;13:e0198812. [PMID: 29912922 DOI: 10.1371/journal.pone.0198812] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 4.5] [Reference Citation Analysis]
46 Berzigotti A, Saran U, Dufour JF. Physical activity and liver diseases. Hepatology. 2016;63:1026-1040. [PMID: 26313307 DOI: 10.1002/hep.28132] [Cited by in Crossref: 84] [Cited by in F6Publishing: 79] [Article Influence: 12.0] [Reference Citation Analysis]
47 Montgomery J, Englesbe M. Sarcopenia in Liver Transplantation. Curr Transplant Rep 2019;6:7-15. [PMID: 31595213 DOI: 10.1007/s40472-019-0223-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
48 Schneider CV, Zandvakili I, Thaiss CA, Schneider KM. Physical activity is associated with reduced risk of liver disease in the prospective UK Biobank cohort. JHEP Rep 2021;3:100263. [PMID: 33898961 DOI: 10.1016/j.jhepr.2021.100263] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
49 Mikkelsen MR, Hendriksen C, Schiødt FV, Rydahl-hansen S. Alcoholic liver disease patients’ perspective of a coping and physical activity-oriented rehabilitation intervention after hepatic encephalopathy. J Clin Nurs 2016;25:2457-67. [DOI: 10.1111/jocn.13265] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
50 Anand AC. Nutrition and Muscle in Cirrhosis. J Clin Exp Hepatol. 2017;7:340-357. [PMID: 29234200 DOI: 10.1016/j.jceh.2017.11.001] [Cited by in Crossref: 54] [Cited by in F6Publishing: 51] [Article Influence: 10.8] [Reference Citation Analysis]
51 Merli M, Lattanzi B, Aprile F. Sarcopenic obesity in fatty liver. Curr Opin Clin Nutr Metab Care 2019;22:185-90. [PMID: 30893090 DOI: 10.1097/MCO.0000000000000558] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
52 Hanai T, Shiraki M, Ohnishi S, Miyazaki T, Ideta T, Kochi T, Imai K, Suetsugu A, Takai K, Moriwaki H, Shimizu M. Rapid skeletal muscle wasting predicts worse survival in patients with liver cirrhosis: Skeletal muscle wasting and survival in cirrhosis. Hepatol Res 2016;46:743-51. [DOI: 10.1111/hepr.12616] [Cited by in Crossref: 88] [Cited by in F6Publishing: 77] [Article Influence: 14.7] [Reference Citation Analysis]
53 Bellar A, Welch N, Dasarathy S. Exercise and physical activity in cirrhosis: opportunities or perils. J Appl Physiol (1985) 2020;128:1547-67. [PMID: 32240017 DOI: 10.1152/japplphysiol.00798.2019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
54 Locklear CT, Golabi P, Gerber L, Younossi ZM. Exercise as an intervention for patients with end-stage liver disease: Systematic review. Medicine (Baltimore). 2018;97:e12774. [PMID: 30334965 DOI: 10.1097/md.0000000000012774] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
55 Hiraoka A, Michitaka K, Kiguchi D, Izumoto H, Ueki H, Kaneto M, Kitahata S, Aibiki T, Okudaira T, Tomida H, Miyamoto Y, Yamago H, Suga Y, Iwasaki R, Mori K, Miyata H, Tsubouchi E, Kishida M, Ninomiya T, Kohgami S, Hirooka M, Tokumoto Y, Abe M, Matsuura B, Hiasa Y. Efficacy of branched-chain amino acid supplementation and walking exercise for preventing sarcopenia in patients with liver cirrhosis. Eur J Gastroenterol Hepatol. 2017;29:1416-1423. [PMID: 29016470 DOI: 10.1097/meg.0000000000000986] [Cited by in Crossref: 65] [Cited by in F6Publishing: 30] [Article Influence: 16.3] [Reference Citation Analysis]
56 Naseer M, Turse EP, Syed A, Dailey FE, Zatreh M, Tahan V. Interventions to improve sarcopenia in cirrhosis: A systematic review. World J Clin Cases 2019; 7(2): 156-170 [PMID: 30705893 DOI: 10.12998/wjcc.v7.i2.156] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
57 Pimentel CFMG, Amaral ACC, Gonzalez AM, Lai M, Mota DO, Ferraz MLG, Junior WM, Kondo M. Six-minute walking test performance is associated with survival in cirrhotic patients. World J Hepatol 2021; 13(11): 1791-1801 [PMID: 34904046 DOI: 10.4254/wjh.v13.i11.1791] [Reference Citation Analysis]
58 Dasarathy S. Cause and management of muscle wasting in chronic liver disease. Curr Opin Gastroenterol. 2016;32:159-165. [PMID: 26974417 DOI: 10.1097/mog.0000000000000261] [Cited by in Crossref: 13] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
59 Aamann L, Ochoa-Sanchez R, Oliveira M, Tremblay M, Bémeur C, Dam G, Vilstrup H, Aagaard NK, Rose CF. Progressive resistance training prevents loss of muscle mass and strength in bile duct-ligated rats. Liver Int 2019;39:676-83. [PMID: 30394651 DOI: 10.1111/liv.13997] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
60 Trivedi HD, Tapper EB. Interventions to improve physical function and prevent adverse events in cirrhosis. Gastroenterol Rep (Oxf) 2018;6:13-20. [PMID: 29479438 DOI: 10.1093/gastro/gox042] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
61 Ebadi M, Montano-loza AJ. Clinical relevance of skeletal muscle abnormalities in patients with cirrhosis. Digestive and Liver Disease 2019;51:1493-9. [DOI: 10.1016/j.dld.2019.05.034] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
62 Aamann L, Tandon P, Bémeur C. Role of Exercise in the Management of Hepatic Encephalopathy: Experience From Animal and Human Studies. J Clin Exp Hepatol 2019;9:131-6. [PMID: 30765946 DOI: 10.1016/j.jceh.2018.07.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
63 Toshikuni N, Arisawa T, Tsutsumi M. Nutrition and exercise in the management of liver cirrhosis. World J Gastroenterol 2014; 20(23): 7286-7297 [PMID: 24966599 DOI: 10.3748/wjg.v20.i23.7286] [Cited by in CrossRef: 48] [Cited by in F6Publishing: 41] [Article Influence: 6.0] [Reference Citation Analysis]
64 Chen HW, Dunn MA. Arresting frailty and sarcopenia in cirrhosis: Future prospects. Clin Liver Dis (Hoboken) 2018;11:52-7. [PMID: 30992788 DOI: 10.1002/cld.691] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
65 Lin F, Ferrando AA, Dennis RA, Dunn MA, Kim WR, Duarte‐rojo A. Exercise‐Induced Hyperammonemia Does Not Precipitate Overt Hepatic Encephalopathy. Hepatology 2020;72:778-80. [DOI: 10.1002/hep.31148] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
66 Tandon P, Dunn MA, Duarte-Rojo A. Resistance Training Reduces Risk of Sarcopenia in Patients With Cirrhosis. Clin Gastroenterol Hepatol 2020;18:1036-9. [PMID: 31589977 DOI: 10.1016/j.cgh.2019.09.030] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
67 Williams FR, Vallance A, Faulkner T, Towey J, Durman S, Kyte D, Elsharkawy AM, Perera T, Holt A, Ferguson J, Lord JM, Armstrong MJ. Home‐Based Exercise in Patients Awaiting Liver Transplantation: A Feasibility Study. Liver Transpl 2019;25:995-1006. [DOI: 10.1002/lt.25442] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 9.0] [Reference Citation Analysis]
68 Tandon P, Ismond KP, Riess K, Duarte-rojo A, Al-judaibi B, Dunn MA, Holman J, Howes N, Haykowsky MJF, Josbeno DA, Mcneely M. Exercise in cirrhosis: Translating evidence and experience to practice. Journal of Hepatology 2018;69:1164-77. [DOI: 10.1016/j.jhep.2018.06.017] [Cited by in Crossref: 65] [Cited by in F6Publishing: 59] [Article Influence: 16.3] [Reference Citation Analysis]
69 Holeček M. Branched-chain amino acid supplementation in treatment of liver cirrhosis: Updated views on how to attenuate their harmful effects on cataplerosis and ammonia formation. Nutrition 2017;41:80-5. [PMID: 28760433 DOI: 10.1016/j.nut.2017.04.003] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 8.0] [Reference Citation Analysis]
70 Saiman Y, Serper M. Frailty and Sarcopenia in Patients Pre- and Post-Liver Transplant. Clin Liver Dis 2021;25:35-51. [PMID: 33978582 DOI: 10.1016/j.cld.2020.08.004] [Reference Citation Analysis]
71 Yamaguchi T, Makiguchi T, Nakamura H, Yamatsu Y, Hirai Y, Shoda K, Suzuki K, Kim M, Kurozumi S, Motegi SI, Shirabe K, Yokoo S. Impact of muscle volume loss on acute oral mucositis in patients undergoing concurrent chemoradiotherapy after oral cancer resection. Int J Oral Maxillofac Surg 2021;50:1195-202. [PMID: 33414037 DOI: 10.1016/j.ijom.2020.12.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
72 Dunn MA, Josbeno DA, Tevar AD, Rachakonda V, Ganesh SR, Schmotzer AR, Kallenborn EA, Behari J, Landsittel DP, DiMartini AF, Delitto A. Frailty as Tested by Gait Speed is an Independent Risk Factor for Cirrhosis Complications that Require Hospitalization. Am J Gastroenterol 2016;111:1768-75. [PMID: 27575708 DOI: 10.1038/ajg.2016.336] [Cited by in Crossref: 74] [Cited by in F6Publishing: 70] [Article Influence: 12.3] [Reference Citation Analysis]
73 Lai JC, Dodge JL, Kappus MR, Wong R, Mohamad Y, Segev DL, McAdams-DeMarco M. A Multicenter Pilot Randomized Clinical Trial of a Home-Based Exercise Program for Patients With Cirrhosis: The Strength Training Intervention (STRIVE). Am J Gastroenterol 2021;116:717-22. [PMID: 33982941 DOI: 10.14309/ajg.0000000000001113] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
74 Ney M, Gramlich L, Mathiesen V, Bailey RJ, Haykowsky M, Ma M, Abraldes JG, Tandon P. Patient-perceived barriers to lifestyle interventions in cirrhosis. Saudi J Gastroenterol 2017;23:97-104. [PMID: 28361840 DOI: 10.4103/1319-3767.203357] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
75 Yoshiji H, Nagoshi S, Akahane T, Asaoka Y, Ueno Y, Ogawa K, Kawaguchi T, Kurosaki M, Sakaida I, Shimizu M, Taniai M, Terai S, Nishikawa H, Hiasa Y, Hidaka H, Miwa H, Chayama K, Enomoto N, Shimosegawa T, Takehara T, Koike K. Evidence-based clinical practice guidelines for Liver Cirrhosis 2020. J Gastroenterol 2021;56:593-619. [PMID: 34231046 DOI: 10.1007/s00535-021-01788-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
76 Ebadi M, Bhanji RA, Mazurak VC, Montano-Loza AJ. Sarcopenia in cirrhosis: from pathogenesis to interventions. J Gastroenterol 2019;54:845-59. [PMID: 31392488 DOI: 10.1007/s00535-019-01605-6] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 16.3] [Reference Citation Analysis]
77 Román E, García-Galcerán C, Torrades T, Herrera S, Marín A, Doñate M, Alvarado-Tapias E, Malouf J, Nácher L, Serra-Grima R, Guarner C, Cordoba J, Soriano G. Effects of an Exercise Programme on Functional Capacity, Body Composition and Risk of Falls in Patients with Cirrhosis: A Randomized Clinical Trial. PLoS One 2016;11:e0151652. [PMID: 27011355 DOI: 10.1371/journal.pone.0151652] [Cited by in Crossref: 69] [Cited by in F6Publishing: 59] [Article Influence: 11.5] [Reference Citation Analysis]
78 Li AA, Ahmed A, Kim D. Impact of sarcopenia on the progression of nonalcoholic fatty liver disease: a frequently forgotten association. Hepatobiliary Surg Nutr 2019;8:260-1. [PMID: 31245407 DOI: 10.21037/hbsn.2018.12.10] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
79 Tapper EB, Martinez-macias R, Duarte-rojo A. Is Exercise Beneficial and Safe in Patients with Cirrhosis and Portal Hypertension? Curr Hepatology Rep 2018;17:175-83. [DOI: 10.1007/s11901-018-0404-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
80 De Chiara F, Ureta Checcllo C, Ramón Azcón J. High Protein Diet and Metabolic Plasticity in Non-Alcoholic Fatty Liver Disease: Myths and Truths. Nutrients 2019;11:E2985. [PMID: 31817648 DOI: 10.3390/nu11122985] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
81 European Association for the Study of the Liver. European Association for the Study of the Liver. EASL Clinical Practice Guidelines on nutrition in chronic liver disease. J Hepatol. 2019;70:172-193. [PMID: 30144956 DOI: 10.1016/j.jhep.2018.06.024] [Cited by in Crossref: 207] [Cited by in F6Publishing: 160] [Article Influence: 51.8] [Reference Citation Analysis]
82 Chakravarthy MV, Neutel J, Confer S, Zhao P, Tatsuta N, Rebello S, Comb WC, Hamill M, Tramontin T, Carroll S, Afeyan R, Sanyal AJ. Safety, Tolerability, and Physiological Effects of AXA1665, a Novel Composition of Amino Acids, in Subjects With Child-Pugh A and B Cirrhosis. Clin Transl Gastroenterol 2020;11:e00222. [PMID: 32955200 DOI: 10.14309/ctg.0000000000000222] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
83 Nasser I, Perez RM, Reis MS, Dias I, Willardson JM, Miranda H. Cardiovascular Acute Effects of Traditional vs. Paired Set Resistance Training in Patients With Liver Cirrhosis. Res Q Exerc Sport 2020;91:630-9. [PMID: 31999503 DOI: 10.1080/02701367.2019.1696013] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
84 Lafoz E, Campreciós G, García-Calderó H, Anton A, Vilaseca M, Ruart M, Guasch E, Garrabou G, Delgado TC, Martínez-Chantar ML, García-Martínez R, Gracia-Sancho J, Hernández-Gea V, García-Pagán JC. Impact of lifestyle interventions targeting physical exercise and caloric intake on cirrhosis regression in rats. Am J Physiol Gastrointest Liver Physiol 2021;321:G603-16. [PMID: 34585619 DOI: 10.1152/ajpgi.00191.2021] [Reference Citation Analysis]
85 Rombouts K, Bémeur C, Rose CF. Targeting the muscle for the treatment and prevention of hepatic encephalopathy. Journal of Hepatology 2016;65:876-8. [DOI: 10.1016/j.jhep.2016.08.014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
86 Burra P, Giannini EG, Caraceni P, Ginanni Corradini S, Rendina M, Volpes R, Toniutto P. Specific issues concerning the management of patients on the waiting list and after liver transplantation. Liver Int 2018;38:1338-62. [PMID: 29637743 DOI: 10.1111/liv.13755] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
87 Aamann L, Dam G, Rinnov AR, Vilstrup H, Gluud LL. Physical exercise for people with cirrhosis. Cochrane Database Syst Rev 2018;12:CD012678. [PMID: 30575956 DOI: 10.1002/14651858.CD012678.pub2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
88 Tincopa MA, Lyden A, Wong J, Jackson EA, Richardson C, Lok AS. Impact of a Pilot Structured Mobile Technology Based Lifestyle Intervention for Patients with Nonalcoholic Fatty Liver Disease. Dig Dis Sci 2021. [PMID: 33939147 DOI: 10.1007/s10620-021-06922-6] [Reference Citation Analysis]
89 Wallen MP, Woodward AJ, Hall A, Skinner TL, Coombes JS, Macdonald GA. Poor Cardiorespiratory Fitness Is a Risk Factor for Sepsis in Patients Awaiting Liver Transplantation. Transplantation 2019;103:529-35. [DOI: 10.1097/tp.0000000000002360] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
90 Bhanji RA, Carey EJ, Yang L, Watt KD. The Long Winding Road to Transplant: How Sarcopenia and Debility Impact Morbidity and Mortality on the Waitlist. Clinical Gastroenterology and Hepatology 2017;15:1492-7. [DOI: 10.1016/j.cgh.2017.04.004] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 5.8] [Reference Citation Analysis]
91 Moctezuma-Velazquez C, Márquez-Guillén E, Torre A. Obesity in the Liver Transplant Setting. Nutrients 2019;11:E2552. [PMID: 31652761 DOI: 10.3390/nu11112552] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
92 Kumar N, Choudhary NS. Treating morbid obesity in cirrhosis: A quest of holy grail. World J Hepatol 2015; 7(28): 2819-2828 [PMID: 26668693 DOI: 10.4254/wjh.v7.i28.2819] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
93 Aby ES, Saab S. Frailty, Sarcopenia, and Malnutrition in Cirrhotic Patients. Clinics in Liver Disease 2019;23:589-605. [DOI: 10.1016/j.cld.2019.06.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
94 Dunn MA, Josbeno DA, Schmotzer AR, Tevar AD, DiMartini AF, Landsittel DP, Delitto A. The gap between clinically assessed physical performance and objective physical activity in liver transplant candidates. Liver Transpl 2016;22:1324-32. [PMID: 27348200 DOI: 10.1002/lt.24506] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 9.4] [Reference Citation Analysis]
95 Bot D, Droop A, Lucassen CJ, van Veen ME, van Vugt JLA, Shahbazi Feshtali S, Leistra E, Tushuizen ME, van Hoek B. Both muscle quantity and quality are predictors of waiting list mortality in patients with end-stage liver disease. Clin Nutr ESPEN 2021;42:272-9. [PMID: 33745592 DOI: 10.1016/j.clnesp.2021.01.022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
96 Duarte-Rojo A, Ruiz-Margáin A, Montaño-Loza AJ, Macías-Rodríguez RU, Ferrando A, Kim WR. Exercise and physical activity for patients with end-stage liver disease: Improving functional status and sarcopenia while on the transplant waiting list. Liver Transpl 2018;24:122-39. [PMID: 29024353 DOI: 10.1002/lt.24958] [Cited by in Crossref: 73] [Cited by in F6Publishing: 69] [Article Influence: 18.3] [Reference Citation Analysis]
97 Ida S, Kojima Y, Hamaoka S, Urawa N, Araki J, Kaneko R, Murata K. Validity of Japanese version of SARC‐F questionnaire in patients with chronic liver disease. Journal of Gastroenterology and Hepatology 2018;34:947-53. [DOI: 10.1111/jgh.14449] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
98 Trovato F, Aiello F, Larocca L, Taylor-robinson S. The Role of Physical Activity and Nutrition in the Sarcopenia of Cirrhosis. JFMK 2016;1:118-25. [DOI: 10.3390/jfmk1010118] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
99 Macías-Rodríguez RU, Ruiz-Margáin A, Román-Calleja BM, Moreno-Tavarez E, Weber-Sangri L, González-Arellano MF, Fernández-Del-Rivero G, Ramírez-Soto K. Exercise prescription in patients with cirrhosis: Recommendations for clinical practice. Rev Gastroenterol Mex (Engl Ed) 2019;84:326-43. [PMID: 31262552 DOI: 10.1016/j.rgmx.2019.02.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
100 Hanai T, Shiraki M, Miwa T, Watanabe S, Imai K, Suetsugu A, Takai K, Moriwaki H, Shimizu M. Effect of loop diuretics on skeletal muscle depletion in patients with liver cirrhosis. Hepatol Res 2019;49:82-95. [PMID: 30156741 DOI: 10.1111/hepr.13244] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
101 Tapper EB, Baki J, Parikh ND, Lok AS. Frailty, Psychoactive Medications, and Cognitive Dysfunction Are Associated With Poor Patient-Reported Outcomes in Cirrhosis. Hepatology 2019;69:1676-85. [PMID: 30382584 DOI: 10.1002/hep.30336] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 8.3] [Reference Citation Analysis]
102 Tandon P, Tangri N, Thomas L, Zenith L, Shaikh T, Carbonneau M, Ma M, Bailey RJ, Jayakumar S, Burak KW, Abraldes JG, Brisebois A, Ferguson T, Majumdar SR. A Rapid Bedside Screen to Predict Unplanned Hospitalization and Death in Outpatients With Cirrhosis: A Prospective Evaluation of the Clinical Frailty Scale. Am J Gastroenterol 2016;111:1759-67. [PMID: 27481305 DOI: 10.1038/ajg.2016.303] [Cited by in Crossref: 87] [Cited by in F6Publishing: 83] [Article Influence: 14.5] [Reference Citation Analysis]
103 Nishida Y, Ide Y, Okada M, Otsuka T, Eguchi Y, Ozaki I, Tanaka K, Mizuta T. Effects of home-based exercise and branched-chain amino acid supplementation on aerobic capacity and glycemic control in patients with cirrhosis. Hepatol Res. 2017;47:E193-E200. [PMID: 27219825 DOI: 10.1111/hepr.12748] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 5.0] [Reference Citation Analysis]
104 Abdelbasset WK, Nambi G, Elsayed SH, Moawd SA, Ibrahim AA, Verma A, Tantawy SA, Kamel DM, Saleh AK, Aldhafian OR, Nwihadh NB. Prevalence and Nonpharmacological Interventions for Sarcopenia among Cirrhotic Patients. Dis Markers 2021;2021:8866093. [PMID: 33628339 DOI: 10.1155/2021/8866093] [Reference Citation Analysis]
105 Bhanji RA, Montano-Loza AJ, Watt KD. Sarcopenia in Cirrhosis: Looking Beyond the Skeletal Muscle Loss to See the Systemic Disease. Hepatology. 2019;70:2193-2203. [PMID: 31034656 DOI: 10.1002/hep.30686] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 10.0] [Reference Citation Analysis]